Glerup H, Mikkelsen K, Poulsen L, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited.
J Intern Med.
2000;247:260 - 268.
Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety.
Am J Clin Nutr.
1999;69:842 - 856.
Moon JC. A brief history of vitamin D toxicity.
J Appl Nutr. 1997;49:18 - 31.
Shah M, Salhab N, Patterson D, et al. Nutritional rickets still afflict children in north Texas.
Tex Med.
2000;96:64 - 68.
Utiger RD. The need for more vitamin D.
N Engl J Med. 1998;338:828 - 829.
Werbach MR.
Foundations of Nutritional Medicine: A Sourcebook of Clinical Research.
Tarzana, Calif: Third Line Press; 1997:74 - 75.
Gloth FM 3rd, Tobin JD. Vitamin D deficiency in older people.
J Am Geriatr Soc.
1995;43:822 - 828.
Fuller KE, Casparian JM. Vitamin D: balancing cutaneous and systematic considerations.
South Med J. 2001;94:58 - 64.
Holmes RP, Kummerow FA. The relationship of adequate and excessive intake of vitamin D to health and disease.
J Am Coll Nutr. 1983;2:173 - 199.
Roe DA.
Drug-Induced Nutritional Deficiencies. 2nd ed. Westport, Conn: AVI Publishing Company; 1985:164 - 166, 249.
Roe DA, Campbell TC, eds.
Drugs and Nutrients: The Interactive Effects. New York, NY: M Dekker; 1984:505 - 523.
Hodges RE, Adelman RD.
Nutrition in Medical Practice. Philadelphia, Pa: Saunders; 1980:323 - 331.
Bengoa JM, Bolt MJ, Rosenberg IH. Hepatic vitamin D 25-hydroxylase inhibition by cimetidine and isoniazid.
J Lab Clin Med. 1984;104:546 - 552.
Odes HS, Fraser GM, Krugliak P, et al. Effect of cimetidine on hepatic vitamin D metabolism in humans.
Digestion.
1990; 46:61 - 64.
[No authors listed]. Cimetidine inhibits the hepatic hydroxylation of vitamin D.
Nutr Rev
43: 184 - 185, 1985.
Brodie MJ, Boobis AR, Hillyard CJ, et al. Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity.
Clin Pharmacol Ther.
1981;30:363 - 367.
Hahn TJ, Hendin BA, Scharp CR, et al. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.
N Engl J Med.
1972;287:900 - 904.
Jubiz W, Haussler MR, McCain TA, et al. Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs.
J Clin Endocrinol Metab.
1977;44:617 - 621.
Williams C, Netzloff M, Folkerts L, et al. Vitamin D metabolism and anticonvulsant therapy: effect of sunshine on incidence of osteomalacia.
South Med J.
1984;77:834 - 836, 842.
Tomita S, Ohnishi J, Nakano M, et al. The effects of anticonvulsant drugs on vitamin D3-activating cytochrome P-450-linked monooxygenase systems.
J Steroid Biochem Mol Biol.
1991;39:479 - 485.
Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled study.
Ann Intern Med.
1996;125:961 - 968.
Aarskog D, Aksnes L, Markestad T, et al. Heparin-induced inhibition of 1,25-dihydroxyvitamin D formation.
Am J Obstet Gynecol. 1984;148:1141 - 1142.
Haram K, Hervig T, Thordarson H, et al. Osteopenia caused by heparin treatment in pregnancy.
Acta Obstet Gynecol Scand. 1993;72:674 - 675.
Wise PH, Hall AJ. Heparin-induced osteopenia in pregnancy.
Br Med J.
1980;281:110 - 111.
Brodie MJ, Boobis AR, Dollery CT, et al. Rifampicin and vitamin D metabolism.
Clin Pharmacol Ther.
1980;27:810 - 814.
Williams SE, Wardman AG, Taylor GA, et al. Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism.
Tubercle.
1985;66:49 - 54.
Perry W, Erooga MA, Brown J, et al. Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis.
J R Soc Med.
1982;75:533 - 536.
Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
N Engl J Med. 1997;337:670 - 676.
Dawson-Hughes B, Dallal GE, Krall EA, et al. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women.
Ann Intern Med. 1991;115:505 - 512.
Garland FC, Garland CF, Gorham ED, et al. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation.
Prev Med. 1990; 19:614 - 622.
Key SW, Marble M. Studies link sun exposure to protection against cancer.
Cancer Weekly Plus.
November 17, 1997: 5 - 6.
Martinez ME, Giovannucci EL, Colditz GA, et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women.
J Natl Cancer Inst. 1996;88:1375 - 1382.
Kearney J, Giovannucci E, Rimm EB, et al. Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men.
Am J Epidemiol. 1996;143:907 - 917.
James SY, Mackay AG, Colston KW. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells.
J Steroid Biochem Mol Biol. 1996;58:395 - 401.
Taylor JA, Hirvonen A, Watson M, et al. Association of prostate cancer with vitamin D receptor gene polymorphism.
Cancer Res. 1996;56:4108 - 4110.
Douglas WC. Vitamin D scores again.
Second Opinion.
1997;7:4 - 5.
Fuller KE, Casparian JM. Vitamin D: balancing cutaneous and systematic considerations.
South Med J. 2001;94:58 - 64.
Gilchrest BA, Eller MS, Geller AC, et al. The pathogenesis of melanoma induced by ultraviolet radiation.
N Engl J Med.
1999;340:1341-1348.
Studzinski GP, Moore DC. Sunlight - can it prevent as well as cause cancer?
Cancer Res. 1995;55:4014 - 4022.
Blutt SE, Weigel NL. Vitamin D and prostate cancer.
Proc Soc Exp Biol Med. 1999;221:89 - 98.
Vandewalle B, Hornez L, Wattez N, et al. Vitamin-D3 derivatives and breast-tumor cell growth: effect on intracellular calcium and apoptosis.
Int J Cancer. 1995;61:806 - 811.
Hofer H, Ho GM, Peterlik M, et al. Biological effects of 1alpha-hydroxy- and 1beta-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapy.
J Pharmacol Exp Ther. 1999;291:450 - 455.
Tong WM, Kallay E, Hofer H, et al. Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D3 is mediated by mutual modulation of receptor expression.
Eur J Cancer. 1998;34:2119 - 2125.
Ekman P. Genetic and environmental factors in prostate cancer genesis: identifying high-risk cohorts.
Eur Urol. 1999;35:362 - 369.
Peehl DM. Vitamin D and prostate cancer risk.
Eur Urol. 1999;35:392 - 394.
Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation.
Cancer. 1992;70:2861 - 2869.
Moffatt KA, Johannes WU, Miller GJ. 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines.
Clin Cancer Res. 1999;5:695 - 703.
Danielsson C, Torma H, Vahlquist A, et al. Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis.
Int J Cancer. 1999;81:467 - 470.
Evans SR, Houghton AM, Schumaker L, et al. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
J Surg Res. 1996;61:127 - 133.
Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997;30(2 pt 1):150-156.
Scragg R. Sunlight, vitamin D, and cardiovascular disease. In: Crass MF II, Avioli LV, eds.
Calcium Regulating Hormones and Cardiovascular Function. Boca Raton, Fla: CRC Press; 1995:213 - 237.
O'Connell TD, Simpson RU. 1,25-dihydroxyvitamin D3 and cardiac muscle structure and function. In: Crass MF II, Avioli LV, eds.
Calcium-Regulating Hormones and Cardiovascular Function. Boca Raton, Fla: CRC Press; 1995:191-211.
Fuller KE, Casparian JM. Vitamin D: balancing cutaneous and systematic considerations.
South Med J. 2001;94:58 - 64.
Thys-Jacobs S, Donovan D, Papadopoulos A, et al. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome.
Steroids.
1999;64:430 - 435.
Kragballe K. Vitamin D3 analogues in psoriasis.
Dermatologica. 1990;180:110 - 111.
LeBoff MS, Kohlmeier L, Hurwitz S, et al. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
JAMA.
1999;281:1505 - 1511.
Mezquita-Raya P, Munoz-Torres M, De Dios Luna J, et al. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women.
J Bone Miner Res.
2001;16:1408 - 1415.
Sato Y, Asoh T, Kondo I, et al. Vitamin D deficiency and risk of hip fractures among disabled elderly stroke patients.
Stroke.
2001;32:1673 - 1677.
Lips P, Graafmans WC, Ooms ME, et al. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial.
Ann Intern Med. 1996;124:400 - 406.
Hunter D, Major P, Arden N, et al. A randomized controlled trial of vitamin D supplementation on preventing postmenopausal bone loss and modifying bone metabolism using identical twin pairs.
J Bone Miner Res. 2000;15:2276 - 2283.
Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women.
Am J Clin Nutr. 2000;72:745 - 750.
Dawson-Hughes B, Dallal GE, Krall EA, et al. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women.
Ann Intern Med. 1991;115:505 - 512.
Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
N Engl J Med. 1997;337:670 - 676.
Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vitamin D for corticosteroid-induced osteoporosis.
Cochrane Database Syst Rev.
2000;(2):CD000952.
Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D
3
supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med.
1996;125:961 - 968.
Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety.
Am J Clin Nutr. 1999;69:842 - 856.
Moon JC. A brief history of vitamin D toxicity.
J Appl Nutr.
1997;49:18 - 31.
Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D(3) intake exceeding the lowest observed adverse effect level.
Am J Clin Nutr. 2001;73:288 - 294.
Bar-Or D, Gasiel Y. Calcium and calciferol antagonise effect of verapamil in atrial fibrillation.
Br Med J (Clin Res Ed).
1981;282:1585 - 1586.
Riis B, Christiansen C. Actions of thiazide on vitamin D metabolism: a controlled therapeutic trial in normal women early in the postmenopause.
Metabolism.
1985;34:421 - 424.
Lemann J, Gray RW, Maierhofer WJ, et al. Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations.
Kidney Int.
198528:951 - 958.
Crowe M, Wollner L, Griffiths RA. Hypercalcaemia following vitamin D and thiazide therapy in the elderly.
Practitioner.
1984;228:312 - 313.
Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride (1997). Available at www.nap.edu. Accessed October 4, 2001.
Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type I diabetes: a birth-cohort study.
Lancet. 2001;358:1500-1503.
The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus.
Diabetologia.
1999;42:51-54.
Stene LC, Ulriksen J, Magnus P, et al. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring.
Diabetologia. 2000;43:1093-1098.
Pfeifer M, Begerow B, Minne H, et al. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women.
J Bone Miner Res.
2000;15:1113-1118.
Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people.
Am J Clin Nutr.
2002;75:611-615.
Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter.
Psychopharmacology (Berl).
1998;135:319 - 323.
Schou AJ, Heuck C, Wolthers OD. A randomized, controlled lower leg growth study of vitamin D supplementation to healthy children during the winter season.
Ann Hum Biol.
2003;30:214 - 219.
Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial.
BMJ.
2003;326:469.
Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial.
J Bone Miner Res.
2003;18:343 - 351.
Latham NK, Anderson CS, Lee A, et al. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the frailty interventions trial in elderly subjects (FITNESS). J
Am Geriatr Soc. 2003;51:291 - 299.
Último revisado julio 2012 por EBSCO CAM Review Board
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.
Copyright © EBSCO Publishing. All rights reserved.